LLS Translational Research Program | Leukaemia Foundation

LLS Translational Research Program

The Leukaemia Foundation has joined forces with the Snowdome Foundation and America’s The Leukemia & Lymphoma Society (LLS) to fund blood cancer research projects with Australian researchers through the LLS Translational Research Program (TRP). The TRP is an LLS initiative that aims to fund new and innovative research that shows high promise for translating basic biomedical knowledge to clinical application.

The partnership between The Leukemia & Lymphoma Society, Snowdome Foundation and the Leukaemia Foundation allows for increased funding, greater reach and ultimately more blood cancer research to be conducted.

This collaborative partnership has so far agreed to fund four TRP projects to the value of US$2.4million in 2018/19 and an additional two projects to the value of US$1.3million in 2019/20. These projects will focus on vital blood cancer research programs across myeloma, lymphoma and leukaemia.

Visit the LLS TRP site for more information >>

Last updated on December 16th, 2019

Developed by the Leukaemia Foundation in consultation with people living with a blood cancer, Leukaemia Foundation support staff, haematology nursing staff and/or Australian clinical haematologists. This content is provided for information purposes only and we urge you to always seek advice from a registered health care professional for diagnosis, treatment and answers to your medical questions, including the suitability of a particular therapy, service, product or treatment in your circumstances. The Leukaemia Foundation shall not bear any liability for any person relying on the materials contained on this website.

Share this page